These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 3584519)

  • 1. An analysis of steady state chlorpromazine plasma levels in the clinical setting.
    Sramek J; Herrera J; Roy S; Parent M; Hudgins R; Costa J; Alatorre E
    J Clin Psychopharmacol; 1987 Apr; 7(2):117-8. PubMed ID: 3584519
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma-level studies of chlorpromazine following the administration of chlorpromazine hydrochloride and chlorpromazine embonate in chronic schizophrenics.
    Cooper SF; Albert JM; Hillel J; Caille G
    Curr Ther Res Clin Exp; 1973 Feb; 15(2):73-7. PubMed ID: 4632509
    [No Abstract]   [Full Text] [Related]  

  • 3. Interpatient variation and significance of plasma levels of chlorpromazine in psychotic patients.
    March JE; Donato D; Turano P; Turner WJ
    J Med; 1972; 3(3):146-62. PubMed ID: 4508254
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical-pharmacological study with the two isomers (d-, l-) of fenfluramine and its comparison with chlorpromazine and d-amphetamine: blood levels, EEG mapping and safety evaluation.
    Saletu B; Barbanoj MJ; Anderer P; Sieghart W; Grünberger J
    Methods Find Exp Clin Pharmacol; 1993 Jun; 15(5):291-312. PubMed ID: 8412414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in the plasma chlorpromazine level in relation to drug dosage].
    Olajossy M; Przyborowska M; Szumiło H; Misztal G
    Psychiatr Pol; 1986; 20(4):264-7. PubMed ID: 3809306
    [No Abstract]   [Full Text] [Related]  

  • 6. Chlorpromazine plasma levels, adverse effects, and tobacco smoking: case report.
    Stimmel GL; Falloon IR
    J Clin Psychiatry; 1983 Nov; 44(11):420-2. PubMed ID: 6643405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dehalogenation and N-dealkylation of chlorpromazine in patients undergoing chronic treatment].
    Ninci R; Valoti M; Della Corte L; Borghesi R; Nardini M; Moneti G; Andreoli V; Sgaragli GP
    Boll Soc Ital Biol Sper; 1985 Aug; 61(8):1101-4. PubMed ID: 4063098
    [No Abstract]   [Full Text] [Related]  

  • 8. [Level of free and bound chlorpromazine fractions in the blood and urine during chlorpromazine treatment].
    Nurowska K; Szajbel W; Waszkiewicz E; Welbel L
    Psychiatr Pol; 1970; 4(4):435-42. PubMed ID: 5472581
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma protein binding of salicylic acid, phenytoin, chlorpromazine, propranolol and pethidine using equilibrium dialysis and ultracentrifugation.
    Verbeeck RK; Cardinal JA
    Arzneimittelforschung; 1985; 35(6):903-6. PubMed ID: 4026915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of chlorpromazine and clinical response [proceedings].
    van Putten T; May PR; Jenden DJ
    Psychopharmacol Bull; 1981 Jan; 17(1):113-5. PubMed ID: 7232637
    [No Abstract]   [Full Text] [Related]  

  • 11. [Electric interphasic blood potential for sodium and potassium ions in patients treated with chlorpromazine for various mental disorders].
    Bichoński R
    Psychiatr Pol; 1972; 6(2):131-6. PubMed ID: 5027437
    [No Abstract]   [Full Text] [Related]  

  • 12. Radioreceptor assay of neuroleptics in refractory chronic schizophrenic patients.
    Lindenmayer JP; Smith D; Katz I
    J Clin Psychiatry; 1984 Mar; 45(3):117-9. PubMed ID: 6142035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary excretion of chlorpromazine metabolites following single doses and in steady-state conditions.
    Hollister LE; Curry SH
    Res Commun Chem Pathol Pharmacol; 1971 May; 2(3):330-8. PubMed ID: 4948435
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic monitoring of chlorpromazine. IV: Comparison of a new high-performance liquid chromatographic method with radioimmunoassays for parent drug and some of its major metabolites.
    Midha KK; Hubbard JW; Cooper JK; Gurnsey T; Hawes EM; McKay G; Chakraborty BS; Yeung PK
    Ther Drug Monit; 1987 Sep; 9(3):358-65. PubMed ID: 3672582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluphenazine decanoate trial in chronic in-patient schizophrenics failing to absorb oral chlorpromazine.
    Adamson L; Curry SH; Bridges PK; Firestone AF; Lavin NI; Lewis DM; Watson RD; Xavier CM; Anderson JA
    Dis Nerv Syst; 1973; 34(4):181-91. PubMed ID: 4711886
    [No Abstract]   [Full Text] [Related]  

  • 16. The determination and possible significance of plasma levels of chlorpromazine in psychiatric patients.
    Curry SH
    Agressologie; 1968; 9(1):115-21. PubMed ID: 5681813
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug plasma levels and clinical effect.
    Crammer JL
    Proc R Soc Med; 1971 Mar; 64(3):289-90. PubMed ID: 5551486
    [No Abstract]   [Full Text] [Related]  

  • 18. The computer analyzes two psychotherapeutic agents in anxiety-depressed states.
    Falk MA
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):488-99. PubMed ID: 4198312
    [No Abstract]   [Full Text] [Related]  

  • 19. A double-blind comparison of mesoridazine and chlorpromazine in chronic schizophrenics.
    Freeman H
    Dis Nerv Syst; 1973; 34(6):289-93. PubMed ID: 4782285
    [No Abstract]   [Full Text] [Related]  

  • 20. The simultaneous measurement of chlorpromazine, chlorpromazine sulfoxide and their demethylated analogs in plasma by radioactive derivative formation.
    Efron DH; Manian AA; Harris SR
    Psychopharmacol Bull; 1970 Jan; 6(1):73-80. PubMed ID: 5432937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.